Proove Biosciences CFO Russell Skibsted Nominated CFO of the Year by the Orange County Business Journal

Life sciences industry leader nominated for prestigious Southern California award

Irvine, CA (PRWEB) October 28, 2015

Proove Biosciences, a commercial and research leader in Personalized Medicine, is excited to announce that the Company’s Chief Financial Officer, Russell Skibsted, has been nominated as an Outstanding CFO of a Private Company by The Orange County Business Journal. The CFO of The Year Awards honors outstanding performances by corporate financial officers in Orange County, CA, for the preceding fiscal year.

“Russell is an important part of the Proove team and we are excited to see a key executive on our team receive this normination,” said Brian Meshkin, founder and CEO of Proove Biosciences. “In his time here at Proove, Russell has help grow our financial infrastructure from an oversized start-up to a company prepared for the next stages of our growth.”

“It is a true honor to be considered for such a well-respected award,” said Russell Skibsted. “I am extremely proud to contribute to Proove Biosciences continued success, to be a part of the talented team in Irvine, CA and to receive this honorable recognition from an esteemed organization such as The Orange County Business Journal.”

Awards will be given in each of the following categories: Outstanding CFO of a Public Company, Outstanding CFO of a Private Company, and Outstanding CFO of a Not-for-Profit Company, Rising Star CFO, and the CFO Lifetime Achievement Award. The five award recipients will be announced at the CFO of The Year Awards Dinner and Program on 1/21/16.

About Proove Biosciences
Our Mission is to Change the Future of Medicine. Proove is the proof to improve healthcare decisions. We seek to realize a future when clinicians look back and wonder how they could’ve ever prescribed medications without knowing how a patient would respond. With offices in Southern California and the Baltimore-Washington metropolitan area, the Company is the research leader investigating and publishing data on the genetics of personalized pain medicine with clinical research sites across the United States. Physicians use Proove Biosciences testing to improve outcomes – both safety and efficacy of medical treatment. From a simple cheek swab collected in the office, Proove performs proprietary genetic tests in its CLIA-certified laboratory to identify patients at risk for misuse of prescription pain medications and evaluate their metabolism of medications. For more information, please visit http://www.proovebio.com or call toll free 855-PROOVE-BIO (855-776-6832).

For the original version on PRWeb visit: http://www.prweb.com/releases/2015/10/prweb13048486.htm